By Sacred Leaves Global Medical News | July 2025
As antibiotic resistance accelerates worldwide, bacteriophages—the viruses that kill bacteria—are gaining renewed attention. Here's a comprehensive look at their century-long journey, modern use, and the scientific backing behind their growing acclaim.
1. Discovery and Early History
Bacteriophages were discovered independently by Frederick W. Twort in 1915 in Britain and by Félix d'Hérelle in 1917 at the Pasteur Institute in Paris.
D'Hérelle also observed large-scale bacterial destruction in cultures in 1917, coining phage therapy’s potential intralytix.com+13Wikipedia+13The New Yorker+13.
2. Historic and Modern Research Centers
- George Eliava Institute in Tbilisi, Georgia: Founded in 1923, it remains a hub for phage production and therapy in Eastern Europe PMC+4Wikipedia+4Wikipedia+4.
- Institute of Immunology and Experimental Therapy, Wrocław, Poland: Europe’s leading phage center since 2005 PubMed+14Wikipedia+14PMC+14.
- IPATH at UC San Diego: Pioneering personalized clinical phage therapy trials since 2018 WIRED+5idgph.ucsd.edu+5Wikipedia+5.
- Yale University: Recent advances by Dr. Jyot Antani (MPA assay) facilitate better matching of phage and bacteria The Times of India.
- China (Shanghai): Invested in phage clinical use since 2019 following several investigator-led trials Wikipedia.
3. Countries Using Phage Therapy
4. Why Phages Are a Superior Option
- Precision: Attacks only specific bacteria, sparing beneficial microbiome and reducing resistance idgph.ucsd.edu+8The Guardian+8TIME+8.
- Anti-biofilm: Effectively breaks down protective biofilms where antibiotics fail Wikipedia+1Wikipedia+1.
- Adaptability: Phages evolve alongside bacteria, minimizing long-term resistance concerns WIRED.
- Safe & Effective: Shown to improve lung function in personalized inhaled treatments Nature.
- Synergy with antibiotics: Phages may re-sensitize resistant bacteria The Guardian.
5. Clinical Advances & Expert Opinions
- Multinational retrospective study (100 cases) showed high success rates in complex infections ASM.org+15Nature+15PMC+15.
- Personalized inhalation therapy improved respiratory function measurably .
- MPA assay from Yale enables precise phage matching Wikipedia+7Wikipedia+7The Times of India+7.
- Experts like Lucy Furfaro (Uni. Western Australia) and Steffanie Strathdee (UCSD) emphasize phages’ specificity, ability to penetrate biofilms, and role in reversing antibiotic resistance Wikipedia+6The Guardian+6WIRED+6.
6. The Path Forward
- More clinical trials: Over 90 in progress for cystic fibrosis, chronic UTIs, wound infections The Guardian.
- Regulatory frameworks essential: Harmonizing phage use in the West for compassionate and formal treatment.
- Technological innovation: Nano-delivery, inhaled formulations, CRISPR-equipped phages .
Conclusion:
A century after their discovery, bacteriophages are emerging as a safe, targeted, and adaptable solution to antibiotic resistance. With growing institutional support, regulatory progress, and cutting-edge clinical trials, experts believe phages are among the most promising tools in the fight against superbugs.
Sources:
/360_F_358094748_shwLUwwLKKlF3QqN6lh9ejwU2MAelz2T.jpg)